• Errors Generated by a Point-Of-Care CD4+ T-Lymphocyte Analyser: a Retrospective Observational Study in Nine Countries

      Fajardo, E; Metcalf, C; Piriou, E; Gueguen, M; Maman, D; Chaillet, P; Cox, V; Rumaney, MB; Tunggal, S; Kosack, C; Roberts, T (World Health Organization, 2015-09-01)
      To estimate the proportion of invalid results generated by a CD4+ T-lymphocyte analyser used by Médecins Sans Frontières (MSF) in field projects and identify factors associated with invalid results.
    • Variability of Growth in Children Starting Antiretroviral Treatment in Southern Africa

      Gsponer, Thomas; Weigel, Ralf; Davies, Mary-Ann; Bolton, Carolyn; Moultrie, Harry; Vaz, Paula; Rabie, Helena; Technau, Karl; Ndirangu, James; Eley, Brian; Garone, Daniela; Wellington, Maureen; Giddy, Janet; Ehmer, Jochen; Egger, Matthias; Keiser, Olivia; Institute of Social and Preventive Medicine (ISPM), University of Bern, Finkenhubelweg 11, CH-3012 Bern, Switzerland. (American Academy of Pediatrics, 2012-10)
      Poor growth is an indication for antiretroviral therapy (ART) and a criterion for treatment failure. We examined variability in growth response to ART in 12 programs in Malawi, Zambia, Zimbabwe, Mozambique, and South Africa.